Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 9, 2007, Pages 3360-3365

  Hamanishi, Junzo ^a   Mandai, Masaki ^a   Iwasaki, Masashi ^a   Okazaki, Taku ^a   Tanaka, Yoshimasa ^a   Yamaguchi, Ken ^a   Higuchi, Toshihiro ^a   Yagi, Haruhiko ^a   Takakura, Kenji ^a   Minato, Nagahiro ^a   Honjo, Tasuku ^a   Fujii, Shingo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Costimulation; Iimmunohistochemistry; Tumor immunity

Indexed keywords

ANTIBODY; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PARAFFIN; PROGRAMMED CELL DEATH 1 LIGAND 1; PROGRAMMED CELL DEATH 1 LIGAND 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MOLECULAR RECOGNITION; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR IMMUNITY;

ADULT; AGED; ANTIBODIES; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 33847611968     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0611533104     Document Type: Article

References (42)

1. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M (1996) Semin Oncol 23(Suppl 12):40-47.
2. Vaidya AP, Curtin JP (2003) Semin Oncol 30:401-412.
3. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) CA Cancer J Clin 55:10-30.
4. Benedet JL, Bender H, Jones H, III, Ngan HY, Pecorelli S (2000) Int J Gynaecol Obstet 70:209-262.
5. Clemente CG, Mihm MC, Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N (1996) Cancer 77:1303-1310.
6. Jass JR (1986) J Clin Pathol 39:585-589.
7. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) Cancer Res 58:3491-3494.
8. Schumacher K, Haensch W, Roefzaad C, Schlag PM (2001) Cancer Res 61:3932-3936.
9. Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H, Ohtani H (2001) Cancer Res 61:5132-5136.
10. Groh V, Wu J, Yee C, Spies T (2002) Nature 419:734-738.
11. Berzofsky JA, Ahlers JD, Belyakov IM (2001) Nat Rev Immunol 1:209-219.
12. Pardoll DM (2002) Nat Rev Immunol 2:227-238.
13. Lang K, Entschladen F, Weidt C, Zaenker KS (2006) Cancer Immunol Immunother 55:749-760.
14. Chambers CA, Kuhns MS, Egen JG, Allison JP (2001) Annu Rev Immunol 19:565-594.
15. Collins M, Ling V, Carreno BM (2005) Genome Biol 6:223.
16. Greenwald RJ, Freeman GJ, Sharpe AH (2005) Annu Rev Immunol 23:515-548.
17. Okazaki T, Honjo T (2006) Trends Immunol 27:195-201.
18. Ishida Y, Agata Y, Shibahara K, Honjo T (1992) EMBO J 11:3887-3895.
19. Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T (1996) Int Immunol 8:765-772.
20. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) Proc Natl Acad Sci USA 98:13866-13871.
21. Dong H, Zhu G, Tamada K, Chen L (1999) Nat Med 5:1365-1369.
22. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, et al. (2000) J Exp Med 192:1027-1034.
23. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, et al. (2001) Nat Immunol 2:261-268.
24. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, Tsuchiya H (2001) J Exp Med 193:839-846.
25. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, et al. (2002) Nat Med 8:793-800.
26. Konishi J, Yamazaki K, Azuma M, Kinoshita I, Dosaka-Akita H, Nishimura M (2004) Clin Cancer Res 10:5094-5100.
27. Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K, Salomao D, Cheville J, Hirano F, Lin W, et al. (2003) Cancer Res 63:6501-6505.
28. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, et al. (2004) Proc Natl Acad Sci USA 101:17174-17179.
29. Wintterle S, Schreiner B, Mitsdoerffer M, Schneider D, Chen L, Meyermann R, Weller M, Wiendl H (2003) Cancer Res 63:7462-7467.
30. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, et al. (2006) Cancer Res 66:3381-3385.
31. Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, et al. (2003) Nat Med 9:562-567.
32. Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, Mizuno T, Yoriki R, Kashizuka H, Yane K, et al. (2005) Clin Cancer Res 11:2947-2953.
33. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, et al. (2003)N Engl J Med 348:203-213.
34. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, et al. (2004) Nat Med 10:942-949.
35. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, et al. (2005) Proc Natl Acad Sci USA 102:18538-18543.
36. Wu C, Zhu Y, Jiang J, Zhao J, Zhang XG, Xu N (2006) Acta Histochem 108:19-24.
37. Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G, Elkum N, Alshabanah M, Bin Amer S, Tulbah A, et al. (2006) Neoplasia 8:190-198.
38. Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N (2002) Proc Natl Acad Sci USA 99:12293-12297.
39. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R (2006) Nature 439:682-687.
40. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, et al. (2006) Nature 443:350-354.
41. Hirano F, Kaneko K, Tamura H, Dong H, Wang S, Ichikawa M, Rietz C, Flies DB, Lau JS, Zhu G, et al. (2005) Cancer Res 65:1089-1096.
42. Iwai Y, Terawaki S, Honjo T (2005) Int Immunol 17:133-144.